1. Home
  2. TR vs TXG Comparison

TR vs TXG Comparison

Compare TR & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tootsie Roll Industries Inc.

TR

Tootsie Roll Industries Inc.

HOLD

Current Price

$41.51

Market Cap

2.8B

ML Signal

HOLD

Logo 10x Genomics Inc.

TXG

10x Genomics Inc.

HOLD

Current Price

$18.88

Market Cap

2.8B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
TR
TXG
Founded
1896
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Foods
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Staples
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.8B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
TR
TXG
Price
$41.51
$18.88
Analyst Decision
Hold
Analyst Count
0
14
Target Price
N/A
$16.39
AVG Volume (30 Days)
101.7K
2.5M
Earning Date
01-01-0001
05-06-2026
Dividend Yield
0.87%
N/A
EPS Growth
N/A
76.97
EPS
N/A
N/A
Revenue
N/A
$245,893,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$7.32
P/E Ratio
$32.36
N/A
Revenue Growth
N/A
68.06
52 Week Low
$29.13
$6.78
52 Week High
$44.27
$23.56

Technical Indicators

Market Signals
Indicator
TR
TXG
Relative Strength Index (RSI) 69.44 51.38
Support Level $40.92 $17.26
Resistance Level $41.92 $19.78
Average True Range (ATR) 1.07 1.31
MACD 0.23 -0.07
Stochastic Oscillator 69.17 61.02

Price Performance

Historical Comparison
TR
TXG

About TR Tootsie Roll Industries Inc.

Tootsie Roll Industries Inc manufactures and sells confectionery products. Notable varieties include Tootsie Roll and Tootsie Pops, Charms, Blow-Pops, Dots, Junior Mints, Sugar Daddy and Sugar Babies, Andes, Dubble Bubble, Razzles among others. The company sells its products to wholesale distributors and directly to retail stores. Geographically, it generates a majority of its revenue from the United States and rest from Canada, Mexico and other regions.

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

Share on Social Networks: